Comparative cost-effectiveness of the HeartWare versus HeartMate II left ventricular assist devices used in the United Kingdom National Health Service.

Slides:



Advertisements
Similar presentations
Diabetes Management in Long-Term Care: An Exploratory Study of the Current Practices and Processes to Managing Frail Elderly Persons with Type 2 Diabetes.
Advertisements

2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.
Dual-site right ventricular and left ventricular pacing in a patient with left ventricular systolic dysfunction and atrial fibrillation using a standard.
ABO-incompatible heart transplantation in early childhood: An international multicenter study of clinical experiences and limits Simon Urschel, MD, Ingrid.
How surgeons can find information online? Martin Hewitt International Journal of Surgery Volume 5, Issue 6, Pages (December 2007) DOI: /j.ijsu
Systolic blood pressure on discharge after left ventricular assist device insertion is associated with subsequent stroke Michael E. Nassif, MD, Anjan Tibrewala,
Sixth INTERMACS annual report: A 10,000-patient database James K. Kirklin, MD, David C. Naftel, PhD, Francis D. Pagani, MD, PhD, Robert L. Kormos, MD,
Janet T. Lee, MD, Rosemary F. Kelly, MD, Marshall I
Management of Anticoagulation in Patients with Mechanical Circulatory Support Using a Physician-Based Versus a Pharmacist Directed Anticoagulation Clinic-Based.
Identifying patients for advanced heart failure therapy by screening patients with cardiac resynchronization therapy or implantable cardioverter-defibrillator:
De novo donor-specific HLA antibodies are associated with early and high-grade bronchiolitis obliterans syndrome and death after lung transplantation 
The Journal of Heart and Lung Transplantation
Impact of aortic valve closure on adverse events and outcomes with the HeartWare ventricular assist device  David Dobarro, MD, Marian Urban, MD, Karen.
T. Oyaizu, S.-Y. Fung, A. Shiozaki, B. Han, S. Keshavjee, M. Liu 
James K. Kirklin, MD, Francis D. Pagani, MD, PhD, Robert L
Can the Seattle Heart Failure Model Be Used to Risk-stratify Heart Failure Patients for Potential Left Ventricular Assist Device Therapy?  Wayne C. Levy,
Jennifer A. Cowger, MD, Matthew A
The Journal of Heart and Lung Transplantation
National Guidelines for Nursing Delegation
The Journal of Heart and Lung Transplantation
Impact of initial Norwood shunt type on young hypoplastic left heart syndrome patients listed for heart transplant: A multi-institutional study  Waldemar.
The Journal of Heart and Lung Transplantation
Boot Camp for Ventricular Assist Device Patient Recovery beyond Medical Management  E.A. Hamad, V. Devlin, K. McDonnell, N. Robinson, M. Welsh, E. Kerr,
Limitations of right heart catheterization in the diagnosis and risk stratification of patients with pulmonary hypertension related to left heart disease:
Pre-operative mortality risk assessment in patients with continuous-flow left ventricular assist devices: Application of the HeartMate II risk score 
Adverse Events in Children Implanted With Ventricular Assist Devices in the US: Data From the Pediatric Interagency Registry for Mechanical Circulatory.
Outcomes in highly sensitized pediatric heart transplant patients using current management strategies  Alfred Asante-Korang, MD, Ernest K. Amankwah, PhD,
Severe Mitral Regurgitation at Time of Left Ventricular Assist Device Implantation - Comparison of Systematic Mitral Valve Repair vs Surgical Abstention 
Survival on the Heart Transplant Waiting List: Impact of Continuous Flow Left Ventricular Assist Device as Bridge to Transplant  Jaimin R. Trivedi, MD,
ALK FISH and IHC: You Cannot Have One without the Other
The American Association for Thoracic Surgery 2016 Ethics Forum: Cost-effectiveness and the ethics of left ventricular assist device therapy  John W.C.
Shinichi Fukuhara, MD, Koji Takeda, MD, PhD, Paul A
Outcomes of Second-Line Chemotherapy in Patients with Relapsed Extensive Small Cell Lung Cancer  Sandra Froeschl, MD, Garth Nicholas, MD, FRCPC, Victor.
Association of device surface and biomaterials with immunologic sensitization after mechanical support  Isaac George, MD, Patrick Colley, BS, Mark J.
Does the method of lung preservation influence outcome after transplantation? An analysis of 681 consecutive procedures  J. Saravana Ganesh, FRCS, Chris.
Martin Strueber, MD, Anna L
A tale of two centrifugal left ventricular assist devices
Characterization of ventricular assist device–mediated sensitization in the bridge-to- heart-transplantation patient  Murray H. Kwon, MD, Jennifer Q. Zhang,
MediGuide-assisted atrial flutter ablation in a patient with a HeartMate II left ventricular assist device  Hien Kiem Nguyen Thanh, MD, Jason Andrade,
CLINICAL DIFFERENCES BETWEEN CONTEMPORARY CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICES: A SINGLE CENTER COMPARISON BETWEEN HEARTWARE, HEARTMATE II.
Effects on pre- and posttransplant pulmonary hemodynamics in patients with continuous-flow left ventricular assist devices  Ranjit John, MD, Kenneth Liao,
Centers for Disease Control “increased-risk” organ donor: Not so risky?  Francis D. Pagani, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery 
Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: Incidence, risk factors, and effect on outcomes 
Katherine Webber, MBBS, MSc, PhD, Andrew N. Davies, FRCP, Martin R
Continuous-Flow Left Ventricular Assist Device Implantation in Patients With a Small Left Ventricle  Masashi Kawabori, MD, Chitaru Kurihara, MD, Tadahisa.
A technique for implanting outflow cannulas for Berlin Heart EXCOR ventricular assist device in small pediatric patients  Khanh Nguyen, MD  The Journal.
Expanding left ventricular assist device use to patients with disabilities: The role of assistive technology  Juan A. Crestanello, MD  The Journal of.
Cost-effectiveness of left ventricular assist devices (LVADs) for patients with advanced heart failure: Analysis of the British NHS bridge to transplant.
Discussions in Cardiothoracic Treatment and Care: Mechanical Circulatory Support Left Ventricular Assist Device Therapy for Patients With Advanced Heart.
Aditya K. Kaza, MD  The Journal of Thoracic and Cardiovascular Surgery 
Adverse events in contemporary continuous-flow left ventricular assist devices: A multi- institutional comparison shows significant differences  John M.
Seeing a tree through the forest: Precision medicine tools can enhance donor allocation in heart transplantation  Vishnu Vasanthan, MD, Paul W.M. Fedak,
Left ventricular assist device therapy in a patient with hearing and speech disabilities  Sotirios Spiliopoulos, MD, PhD, Vera Hergesell, MD, Otto Dapunt,
Nicholas A. Haglund, MD, Mary E. Davis, MS, CCRP, Nicole M
Experience from an American Association for Thoracic Surgery Foundation for Thoracic Surgery Training Fellowship: Lung transplantation in Toronto General.
A first start for lung transplantation?
Right ventricular failure after cardiac surgery: Why can't right ventricular assist device support fix the problem?  Francis D. Pagani, MD, PhD  The Journal.
Successful combined procedure of HeartMate II left ventricular assist device implantation and minimally invasive transapical aortic valve replacement 
Durability of left ventricular assist devices: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 2006 to 2011  William L.
Commentary: It's time to check our bias: Ensuring health equity for patients with lung cancer  Pamela Samson, MD, MPHS  The Journal of Thoracic and Cardiovascular.
Minimally invasive off-pump implantation of HeartMate 3 left ventricular assist device  Diyar Saeed, MD, PhD, Stephan Sixt, MD, PhD, Alexander Albert,
Volume 10, Issue 4, Pages (April 2013)
Martin Strueber, MD, Jan D
Anticoagulation with apixaban in a patient with a left ventricular assist device and gastrointestinal bleeding: A viable alternative to warfarin?  Francesco.
Roger Hakimian, MD, Hongbin Fang, PhD, Leno Thomas, MD, Martin J
Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices  Forum Kamdar, MD, Ranjit John,
Current Status of Left Ventricular Assist Device Therapy
Optimal timing for heart transplantation in patients bridged with left ventricular assist devices: Is timing of the essence?  Chase R. Brown, MD, Fabliha.
Did you like Terminator 3 better than Terminator 2
Hari R. Mallidi, MD  The Journal of Thoracic and Cardiovascular Surgery 
Presentation transcript:

Comparative cost-effectiveness of the HeartWare versus HeartMate II left ventricular assist devices used in the United Kingdom National Health Service bridge-to-transplant program for patients with heart failure Ruth Pulikottil-Jacob, MSc, Gaurav Suri, MSc, Martin Connock, PhD, Ngianga-Bakwin Kandala, PhD, Paul Sutcliffe, PhD, Hendramoorthy Maheswaran, PhD, Nicholas R. Banner, FRCP, Aileen Clarke, MD The Journal of Heart and Lung Transplantation Volume 33, Issue 4, Pages (April 2014) DOI: /j.healun Copyright © 2014 The Authors Terms and Conditions Terms and Conditions

Figure 1 The Journal of Heart and Lung Transplantation , DOI: ( /j.healun ) Copyright © 2014 The Authors Terms and Conditions Terms and Conditions

Figure 2 The Journal of Heart and Lung Transplantation , DOI: ( /j.healun ) Copyright © 2014 The Authors Terms and Conditions Terms and Conditions

Figure 3 The Journal of Heart and Lung Transplantation , DOI: ( /j.healun ) Copyright © 2014 The Authors Terms and Conditions Terms and Conditions

Figure 4 The Journal of Heart and Lung Transplantation , DOI: ( /j.healun ) Copyright © 2014 The Authors Terms and Conditions Terms and Conditions

Figure 5 The Journal of Heart and Lung Transplantation , DOI: ( /j.healun ) Copyright © 2014 The Authors Terms and Conditions Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2024 SlidePlayer.com Inc. All rights reserved.